Skip to content

Clinical trial Retterspitz lotion in patients with various manifestations of injuries of the muscular, tendon and joint system

Clinical trial Retterspitz lotion in patients with various manifestations of injuries of the muscular, tendon and joint system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00020252
Enrollment
96
Registered
2019-12-11
Start date
2020-03-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

various manifestations of muscle, tendon and joint injuries

Interventions

Group 1: Retterspitz Muscle Lotion Applying three to six times a day. Total duration of the intervention 8 days. Group 2: Placebo

Sponsors

Retterspitz GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: - Patients with acute injuries of the muscles, tendons and joint system, which are not permanently in need of therapy nature. - The trauma must not be older than 48 hours. - Occurrence of at least one of the following complaints: - bruise - Strain - tension - swelling - Sprain - hematoma

Exclusion criteria

Exclusion criteria: - Patients with an open wound on the affected part of the body - Patients with fractures, torn ligaments, surgical interventions, recurrent chronic complaints and local skin infections, which do not allow the study medication. - Patients taking anticoagulation or anti-platelet drugs - permanent use of painkillers - Use of steroidal or non-steroidal anti-inflammatory drugs within 48 hours of the onset of injury (topically, orally or intravenously) - Age 85 - Allergy or intolerance to one or more of the ingredients used - Pregnancy and breast feeding period - Inability to adequately participate in the study

Design outcomes

Primary

MeasureTime frame
Objectifiable representation of the effectiveness of Retterspitz lotion. Measurement of the type of complaint and the intensity of the complaints using a visual analog scale (VAS) from 0 (no complaints) to 10 (strongest complaints imaginable). Change in the symptoms using a standardized questionnaire at identical times (days 1, 4 and 8) by means of standardized assessment of the degree of complaint using a visual analogue scale from 0 (no complaints) to 10 (strongest complaints imaginable)

Secondary

MeasureTime frame
Side effect related to the application

Countries

Germany

Contacts

Public ContactNicole Schuster

Retterspitz GmbH

dr.schuster@retterspitz.de0911-50700-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026